Properties of the COPD assessment test in a cross-sectional European study

被引:265
作者
Jones, P. W. [1 ]
Brusselle, G. [3 ]
Dal Negro, R. W. [4 ]
Ferrer, M. [5 ]
Kardos, P. [7 ]
Levye, M. L. [2 ]
Perez, T. [9 ]
Cataluna, J. J. Soler [6 ]
van der Molen, T. [11 ]
Adamek, L. [10 ]
Banik, N. [8 ]
机构
[1] St Georges Univ London, Div Clin Sci, London SW17 0RE, England
[2] Univ Edinburgh, Div Community Hlth Sci, Edinburgh, Midlothian, Scotland
[3] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium
[4] Orlandi Gen Hosp, Lung Dept, Bussolengo, Italy
[5] IMIM Hosp del Mar Res Inst, Hlth Serv Res Unit, Barcelona, Spain
[6] Requena Gen Hosp, Pneumol Unit, Valencia, Spain
[7] Maingau Hosp, Frankfurt, Germany
[8] GlaxoSmithKline, Biostat & Epidemiol, Munich, Germany
[9] Lille Univ Hosp, Dept Pulmonol, Lille, France
[10] GlaxoSmithKline, Resp Ctr Excellence, Marly Le Roi, France
[11] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
关键词
Chronic obstructive pulmonary disease; COPD assessment test; health-related quality of life; primary care; RELIABILITY; VALIDATION; PHENOTYPES; DISABILITY; OUTCOMES; DISEASE;
D O I
10.1183/09031936.00177210
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
A short, easy-to-use health status questionnaire is needed in the multidimensional assessment of chronic obstructive pulmonary disease (COPD) in routine practice. The performance of the eight-item COPD assessment test (CAT) was analysed in 1,817 patients from primary care in seven European countries. The CAT has a scoring range of 0-40 (high score representing poor health status). Mean CAT scores indicated significant health status impairment that was related to severity of airway obstruction, but within each Global Initiative for Obstructive Lung Disease stage (I to IV) there was a wide range of scores (I: 16.2 +/- 8.8; II: 16.3 +/- 7.9; III: 19.3 +/- 8.2; and IV: 22.3 +/- 8.7; I versus II, p=0.88; II versus III, p<0.0001; III versus IV, p=0.0001). CAT scores showed relatively little variability across countries (within +/- 12% of the mean across all countries). Scores were significantly better in patients who were stable (17.2 +/- 8.3) versus those suffering an exacerbation (21.3 +/- 8.4) (p<0.0001); and in patients with no (17.3 +/- 8.1) or one or two (16.6 +/- 8.2) versus three or more (19.7 +/- 8.5) comorbidities (p<0.0001 for both). The CAT distinguished between classes of other impairment measures and was strongly correlated with the St George's Respiratory Questionnaire (r=0.8, p<0.0001). The CAT is a simple and easy-to-use questionnaire that distinguishes between patients of different degrees of COPD severity and appears to behave the same way across countries.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 18 条
  • [1] Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
    Bestall, JC
    Paul, EA
    Garrod, R
    Garnham, R
    Jones, PW
    Wedzicha, JA
    [J]. THORAX, 1999, 54 (07) : 581 - 586
  • [2] Clinical COPD phenotypes: a novel approach using principal component and cluster analyses
    Burgel, P-R.
    Paillasseur, J-L.
    Caillaud, D.
    Tillie-Leblond, I.
    Chanez, P.
    Escamilla, R.
    Court-Fortune, I.
    Perez, T.
    Carre, P.
    Roche, N.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) : 531 - 539
  • [3] Outcomes for COPD pharmacological trials:: from lung function to biomarkers
    Cazzola, M.
    MacNee, W.
    Martinez, F. J.
    Rabe, K. F.
    Franciosi, L. G.
    Barnes, P. J.
    Brusasco, V.
    Burge, P. S.
    Calverley, P. M. A.
    Celli, B. R.
    Jones, P. W.
    Mahler, D. A.
    Make, B.
    Miravitlles, M.
    Page, C. P.
    Palange, P.
    Parr, D.
    Pistolesi, M.
    Rennard, S. I.
    Moelken, M. P. Rutten-Van
    Stockley, R.
    Sullivan, S. D.
    Wedzicha, J. A.
    Wouters, E. F.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (02) : 416 - 468
  • [4] Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
    Celli, BR
    MacNee, W
    Agusti, A
    Anzueto, A
    Berg, B
    Buist, AS
    Calverley, PMA
    Chavannes, N
    Dillard, T
    Fahy, B
    Fein, A
    Heffner, J
    Lareau, S
    Meek, P
    Martinez, F
    McNicholas, W
    Muris, J
    Austegard, E
    Pauwels, R
    Rennard, S
    Rossi, A
    Siafakas, N
    Tiep, B
    Vestbo, J
    Wouters, E
    ZuWallack, R
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) : 932 - 946
  • [5] Health-related quality of life in patients by COPD severity within primary care in Europe
    Jones, P. W.
    Brusselle, G.
    Dal Negro, R. W.
    Ferrer, M.
    Kardos, P.
    Levy, M. L.
    Perez, T.
    Soler-Cataluna, J. J.
    van der Molen, T.
    Adamek, L.
    Banik, N.
    [J]. RESPIRATORY MEDICINE, 2011, 105 (01) : 57 - 66
  • [6] Development and first validation of the COPD Assessment Test
    Jones, P. W.
    Harding, G.
    Berry, P.
    Wiklund, I.
    Chen, W-H.
    Leidy, N. Kline
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (03) : 648 - 654
  • [7] Jones Paul, 2009, Prim Care Respir J, V18, P208, DOI 10.4104/pcrj.2009.00053
  • [8] Interpreting thresholds for a clinically significant change in health status in asthma and COPD
    Jones, PW
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (03) : 398 - 404
  • [9] Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
    Mannino, D. M.
    Thorn, D.
    Swensen, A.
    Holguin, F.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (04) : 962 - 969
  • [10] Development and validation of an improved, COPD-Specific version of the St. George respiratory questionnaire
    Meguro, Makiko
    Barley, Elizabeth A.
    Spencer, Sally
    Jones, Paul W.
    [J]. CHEST, 2007, 132 (02) : 456 - 463